Smooth muscle progenitor cells: friend or foe in vascular disease?

Olivia van Oostrom1, Joost O Fledderus, Dominique de Kleijn

  • 1Department of Vascular Medicine, University Medical Center Utrecht, The Netherlands.

Insights

The origin of vascular smooth muscle cells in neointima formation is debated. This review explores the role of bone marrow-derived smooth muscle progenitor cells in vascular disease, aiding therapeutic development.

Area of Science:

  • Vascular Biology
  • Cellular Heterogeneity
  • Regenerative Medicine

Background:

  • Vascular smooth muscle cell (VSMC) origin in neointima formation is debated in diseases like atherosclerosis.
  • VSMCs are heterogeneous, exhibiting distinct phenotypes in health and disease.
  • Bone marrow-derived progenitor cells (BMSPCs) are implicated in vascular repair.

Purpose of the Study:

  • To review the heterogeneity of VSMCs.
  • To discuss the role of BMSPCs in vascular disease and neointima formation.
  • To explore therapeutic strategies targeting BMSPCs for vascular disease prevention.

Main Methods:

  • Literature review of studies on VSMC heterogeneity.
  • Analysis of research on BMSPCs in vascular disease models.
  • Discussion of potential regulatory mechanisms and therapeutic implications.

Main Results:

  • BMSPCs have been detected in human atherosclerotic tissue and mouse models.
  • The contribution of BMSPCs to neointima formation ('friend' or 'foe') is unclear.
  • Understanding BMSPC roles is crucial for developing novel therapies.

Conclusions:

  • VSMC heterogeneity is a key factor in vascular disease.
  • BMSPCs may play a significant role in neointima formation.
  • Targeting BMSPCs offers potential for novel therapeutic interventions in vascular diseases.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Structure of Blood Vessels01:15

Structure of Blood Vessels

Blood is circulated throughout the human body through a network of blood vessels called the circulatory system. This system includes arteries that transport blood from the heart to various body parts. These arterial pathways divide into smaller vessels until they reach the arterioles, which further split into capillaries. It is within these minuscule capillaries that the exchange of nutrients and waste products takes place. After this exchange, the blood is collected by venules, which fuse to...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...